Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...

Across healthcare system, stakeholders share blame for high costs. This includes hospitals, drugmakers, insurers and others ...

The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...

CHICAGO U.S. Senate Democratic Whip Dick Durbin (D-IL) and U.S. Senator Chuck Grassley (R-IA), a senior member and former ...

Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...

We agree that direct-to-consumer prescription-drug advertisements need to be reformed.

As advertisers pay more for an ever-scarcer supply of ratings points, pharma’s ironclad devotion to TV could finally be in jeopardy ...

A new study published in JAMA Network Open has found that while procedural prescription denials curb immediate drug costs, some denials result in increased acute care utilization and costs, which ...

Congress nearly passed legislation to restrict pharmacy benefit manager business practices at the end of 2024.

IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...

In a flurry of executive orders signed just hours after he took office, President Donald Trump rescinded a Biden administration order on prescription drugs.